PL364526A1 - Sposób hamowania tworzenia zrostów - Google Patents

Sposób hamowania tworzenia zrostów

Info

Publication number
PL364526A1
PL364526A1 PL02364526A PL36452602A PL364526A1 PL 364526 A1 PL364526 A1 PL 364526A1 PL 02364526 A PL02364526 A PL 02364526A PL 36452602 A PL36452602 A PL 36452602A PL 364526 A1 PL364526 A1 PL 364526A1
Authority
PL
Poland
Prior art keywords
adhesion formation
inhibiting adhesion
inhibiting
formation
adhesion
Prior art date
Application number
PL02364526A
Other languages
English (en)
Inventor
Robert N. Willette
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL364526A1 publication Critical patent/PL364526A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
PL02364526A 2001-04-10 2002-04-10 Sposób hamowania tworzenia zrostów PL364526A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28269301P 2001-04-10 2001-04-10
PCT/US2002/011285 WO2002083125A1 (en) 2001-04-10 2002-04-10 Method of inhibiting adhesion formation

Publications (1)

Publication Number Publication Date
PL364526A1 true PL364526A1 (pl) 2004-12-13

Family

ID=23082703

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364526A PL364526A1 (pl) 2001-04-10 2002-04-10 Sposób hamowania tworzenia zrostów

Country Status (26)

Country Link
EP (1) EP1385504B1 (pl)
JP (1) JP4394882B2 (pl)
KR (1) KR20030087069A (pl)
CN (1) CN1248692C (pl)
AP (1) AP2003002894A0 (pl)
AT (1) ATE417612T1 (pl)
AU (1) AU2002305164B2 (pl)
BG (1) BG108217A (pl)
BR (1) BR0208789A (pl)
CA (1) CA2443734A1 (pl)
CZ (1) CZ20032767A3 (pl)
DE (1) DE60230404D1 (pl)
EA (1) EA006202B1 (pl)
EC (1) ECSP034799A (pl)
ES (1) ES2319877T3 (pl)
HU (1) HUP0303725A3 (pl)
IL (1) IL158272A0 (pl)
MA (1) MA26159A1 (pl)
MX (1) MXPA03009344A (pl)
NO (1) NO20034513L (pl)
NZ (1) NZ528577A (pl)
OA (1) OA12505A (pl)
PL (1) PL364526A1 (pl)
UA (1) UA75395C2 (pl)
WO (1) WO2002083125A1 (pl)
ZA (1) ZA200307621B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200635902A (en) * 2004-12-21 2006-10-16 Smithkline Beecham Corp Methods and formulations
RU2744540C1 (ru) * 2020-02-18 2021-03-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики спаечного процесса при операциях на брюшной полости в условиях паренхиматозного кровотечения в эксперименте

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція

Also Published As

Publication number Publication date
ECSP034799A (es) 2004-01-28
JP2004525959A (ja) 2004-08-26
EP1385504A4 (en) 2007-03-14
HUP0303725A3 (en) 2009-08-28
CZ20032767A3 (cs) 2004-12-15
OA12505A (en) 2006-05-29
NO20034513D0 (no) 2003-10-08
IL158272A0 (en) 2004-05-12
ZA200307621B (en) 2004-04-21
AU2002305164B2 (en) 2005-07-28
CA2443734A1 (en) 2002-10-24
AP2003002894A0 (en) 2003-12-31
CN1248692C (zh) 2006-04-05
ATE417612T1 (de) 2009-01-15
MXPA03009344A (es) 2004-02-12
DE60230404D1 (pl) 2009-01-29
NO20034513L (no) 2003-12-04
UA75395C2 (en) 2006-04-17
NZ528577A (en) 2005-01-28
ES2319877T3 (es) 2009-05-14
EA200301109A1 (ru) 2004-02-26
BG108217A (bg) 2004-12-30
KR20030087069A (ko) 2003-11-12
EA006202B1 (ru) 2005-10-27
WO2002083125A1 (en) 2002-10-24
EP1385504A1 (en) 2004-02-04
CN1509170A (zh) 2004-06-30
MA26159A1 (fr) 2004-07-01
HUP0303725A2 (hu) 2004-03-01
BR0208789A (pt) 2004-03-09
EP1385504B1 (en) 2008-12-17
JP4394882B2 (ja) 2010-01-06

Similar Documents

Publication Publication Date Title
PL369170A1 (pl) Środek zmniejszający przyczepność pleśni do powierzchni, środek do prania, czyszczenia i zmywania oraz środek do opakowań, mediów filtracyjnych, materiałów budowlanych, pomocniczych materiałów budowlanych, materiałów tekstylnych, futer, papierów, skór surowych lub wyprawionych oraz klej i masa uszczelniająca, zawierające środki zmniejszające przyczepnośc pleśni
GB2415613B (en) Method of cleaning
GB0316926D0 (en) Method of coating
GB0125622D0 (en) Method of polymerisation
GB2392676B (en) Method of depositing aluminium nitride
PL355161A1 (en) Method of manufacture
EP1577280A4 (en) DEUTERATION PROCESS
AU2003255924A8 (en) Method of electrostatic deposition
GB2360717B (en) Method of forming coatings
IL160812A0 (en) Method of attachment
EP1360455A4 (en) BLASTING METHOD
EP1488046A4 (en) CONSTRUCTION METHODS
IL158004A0 (en) Method of enhancing entomophilous
GB2371731B (en) Method of alignment
AU2002352120A8 (en) Coating method
HUP0303725A3 (en) Method of inhibiting adhesion formation
EP1401286A4 (en) METHOD FOR INHIBITING MUSHROOM GROWTH
HK1062884A (en) Method of inhibiting adhesion formation
PL356317A1 (en) Method of obtaining alkanosulphonylpyridines
PL347523A1 (en) Method of obtaining 11alpha-hydroxy-1-dehydrotestosterone
GB0122333D0 (en) Method of forming nitride films
AU2003268338A8 (en) Method of resisting osteoclast formation
HU0100184V0 (en) Method for forming of smokingset
GB0104109D0 (en) Method of manufacture
GB0100867D0 (en) Method of increasing the effective thickness of inusulation

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)